Dr Reddy's gets prelim FDA nod for asthma drug

10 Jun 2010 Evaluate

Dr Reddy's Laboratories (REDY.BO) has got tentative approval from U.S. regulators to launch the generic version of AstraZeneca's (AZN.L) Accolate, used to treat asthma.

The company is currently working on manufacturing plans for zafirlukast, the generic name of Accolate, and will decide the time of its launch after getting the final approval from the U.S. Food & Drug Administration. The company expects the launch of more than a dozen new drugs in the United States to boost growth in this financial year. crackcrack

Dr. Reddys Lab Share Price

1342.45 16.45 (1.24%)
20-Dec-2024 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1808.50
Dr. Reddys Lab 1342.45
Cipla 1472.45
Lupin 2147.55
Zydus Lifesciences 973.90
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.